Snub for Imran Khan: No US welcome at airport, takes metro to Pakistan envoy’s house

Agencies
July 22, 2019

Washington/Islamabad, Jul 22: With his country in financial doldrums, Khan made it a point to travel by a commercial flight, Qatar Airways, instead of a private jet, to cut down expenses.

When his flight touched down at Dulles airport, reportedly there was no high ranking US administration official to welcome him.

Later, Khan took a metro ride to the Pakistani envoy’s house.

Social media was awash with speculation that Khan had been snubbed by the US administration, and that the Pakistani government had offered to pay $250,000 for the State Department to arrange an official welcome/protocol of the visiting Pakistani premier, but it was refused.

Pakistan Foreign Minister Shah Mehmood Qureshi was at the airport to receive Khan and also accompanied him on the metro ride.

Acting Chief of Protocol, Mary-Kate Fisher, who had welcomed the Pakistan Prime Minister at the airport, accompanied him on the metro ride.

The State Department later said the Acting Chief of Protocol had received the visiting Prime Minister, “as is standard for an Official Working Visit to the White House”.

Imran Khan, who is staying at the official residence of the Pakistani Ambassador to the US, Asad Majeed Khan, is to meet US President Donald Trump on July 22.

Khan, who was lustily greeted by members of the Pakistani expatriate community, later met with the Pakistani business community.

During his three-day visit, Khan is also to meet IMF acting chief David Lipton and World Bank President David Malpass.

Chief of the Army Staff Gen. Qamar Javed Bajwa and the Director General of Inter-Services Intelligence (ISI) are accompanying Khan to the US.

The Pakistan Embassy in Washington has hired the services of top lobbying firm Holland & Knight to help advance the country’s interests in the US.

His visit comes as Pakistan has received a $6 billion bailout from the International Monetary Fund (IMF) despite concerns expressed by the US.

According to the White House, Khan’s visit will focus on strengthening cooperation between Washington and Islamabad to bring peace, stability and economic prosperity to a region that has seen far too much conflict.

Comments

Abrar Lahore
 - 
Tuesday, 23 Jul 2019

1)    he was on family trip to United States. not official trip.
2)    If there is no official work, foreign leaders have to pay money to US govt to get official welcome. Khan did not waste pakitan’s public money. He decided not to pay.

Mr Frank
 - 
Tuesday, 23 Jul 2019

Welcome or not welcome will not change anyones good work in office.Pakistan recieved 6 billion from IMF where as India is loosing IMF funding bcoz of our violent culture of mobing lyching raping killings.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 27,2020

Chengdu, China, Jul 27: The American flag was lowered at the United States consulate in Chengdu on Monday, days after Beijing ordered it to close in retaliation for the shuttering of the Chinese consulate in Houston.

Footage on state broadcaster CCTV from outside the consulate showed the flag being slowly lowered early Monday morning, after diplomatic tensions soared between the two powers with both alleging the other had endangered national security.

Relations deteriorated in recent weeks in a Cold War-style standoff, with the Chengdu mission Friday ordered to shut in retaliation for the forced closure of Beijing's consulate in Houston, Texas.

The deadline for the Americans to exit Chengdu has been unclear, but the Chinese consulate in Houston was given 72 hours to close after the original order was made.

On Saturday news agency reporters saw workers removing the US insignia from the front of the consulate.

Over the weekend, removals trucks entered the US consulate and cleaners were seen carting large black rubbish bags from the building.

Beijing says closing the Chengdu consulate was a "legitimate and necessary response to the unreasonable measures by the United States", and has alleged that staff at the diplomatic mission endangered China's security and interests.

Washington officials, meanwhile, said there had been unacceptable efforts by the Chinese consulate in Houston to steal US corporate secrets.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 31,2020

New Delhi, Jul 31: With the highest single-day spike of 55,079 COVID-19 cases in the last 24 hours, India's coronavirus tally breached the 16 lakh mark on Friday, informed the Union Ministry of Health and Family Welfare.

With this latest spike, the total cases in the country stand at 16,38,871. Among these cases 5,45,318 are active. A total of 10,57,806 patients have been cured/discharged/migrated.

779 deaths due to COVID-19 have been reported in the country in the last 24 hours, taking the death toll to 35,747.

As per the Union Health Ministry, Maharashtra has a total of 1,48,454 active cases and recorded 14,729 deaths due to COVID-19.
Tamil Nadu has a total of 57,962 active cases and 3,838 deaths in the state.

Delhi has a total of 10,743 active cases and 3,936 deaths.

The Indian Council of Medical Research on Friday informed that a total number of COVID-19 samples tested up to 30th July is 1,88,32,970 including 6,42,588 samples tested yesterday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.